EDSA

Edesa Biotech (EDSA)

About Edesa Biotech (EDSA)

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Details

Daily high
$4.30
Daily low
$4.26
Price at open
$4.29
52 Week High
$8.33
52 Week Low
$2.46
Market cap
13.8M
Dividend yield
0.00%
Volume
1,462
Avg. volume
10,745
P/E ratio
-2.47

Edesa Biotech News

Details

Daily high
$4.30
Daily low
$4.26
Price at open
$4.29
52 Week High
$8.33
52 Week Low
$2.46
Market cap
13.8M
Dividend yield
0.00%
Volume
1,462
Avg. volume
10,745
P/E ratio
-2.47